StockData

Chemed Corp (CHE) stock

CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/306% above fair value
$546.72−0.03 (-0.01%)

Close on Nov 18, 2026Market cap $7.12BP/E 26.1Yield 0.40%

Chemed gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Chemed's gross profit for the twelve months ending Sep 30, 2026 was $892.52M, up 6.9% year over year. For fiscal 2025 it was $823.18M, down 3.6% from the year before. Over ten years it grew 6.1% a year on average. The highest annual figure on record is $854.35M in fiscal 2024.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$823.18M-3.6%
FY2024Dec 31, 2024$854.35M+7.0%
FY2023Dec 31, 2023$798.82M+4.4%
FY2022Dec 31, 2022$765.09M-0.6%
FY2021Dec 31, 2021$769.80M+9.8%
FY2020Dec 31, 2020$701.39M+13.6%
FY2019Dec 31, 2019$617.43M+11.2%
FY2018Dec 31, 2018$555.00M+7.5%
FY2017Dec 31, 2017$516.19M+11.9%
FY2016Dec 31, 2016$461.45M+1.2%
FY2015Dec 31, 2015$455.78M+8.1%
FY2014Dec 31, 2014$421.61M+4.2%
FY2013Dec 31, 2013$404.52M+2.0%
FY2012Dec 31, 2012$396.72M+2.9%
FY2011Dec 31, 2011$385.49M+2.9%
FY2010Dec 31, 2010$374.53M+5.3%
FY2009Dec 31, 2009$355.66M+5.1%
FY2008Dec 31, 2008$338.39M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$232.96M+16.6%
Q2 FY2026Jun 30, 2026$221.47M+19.9%
Q1 FY2026Mar 31, 2026$215.76M-0.3%
Q4 FY2025Dec 31, 2025$222.32M-5.0%
Q3 FY2025Sep 30, 2025$199.76M-4.9%
Q2 FY2025Jun 30, 2025$184.69M-10.4%
Q1 FY2025Mar 31, 2025$216.41M+6.0%
Q4 FY2024Dec 31, 2024$234.12M+2.9%
Q3 FY2024Sep 30, 2024$209.99M+3.9%
Q2 FY2024Jun 30, 2024$206.13M+14.8%
Q1 FY2024Mar 31, 2024$204.11M+7.7%
Q4 FY2023Dec 31, 2023$227.57M+15.5%
Q3 FY2023Sep 30, 2023$202.17M+12.6%
Q2 FY2023Jun 30, 2023$179.62M-7.6%
Q1 FY2023Mar 31, 2023$189.45M-2.3%
Q4 FY2022Dec 31, 2022$197.08M-3.7%
Q3 FY2022Sep 30, 2022$179.54M-8.6%
Q2 FY2022Jun 30, 2022$194.47M+7.0%
Q1 FY2022Mar 31, 2022$194.00M+3.8%
Q4 FY2021Dec 31, 2021$204.65M+3.2%
Q3 FY2021Sep 30, 2021$196.50M+3.9%
Q2 FY2021Jun 30, 2021$181.76M+21.1%
Q1 FY2021Mar 31, 2021$186.89M+13.9%
Q4 FY2020Dec 31, 2020$198.24M+13.3%
Q3 FY2020Sep 30, 2020$189.06M+24.0%
Q2 FY2020Jun 30, 2020$150.04M+0.1%
Q1 FY2020Mar 31, 2020$164.05M+17.1%
Q4 FY2019Dec 31, 2019$174.97M+20.3%
Q3 FY2019Sep 30, 2019$152.43M+9.8%
Q2 FY2019Jun 30, 2019$149.95M+10.2%
Q1 FY2019Mar 31, 2019$140.08M+4.0%
Q4 FY2018Dec 31, 2018$145.45M+6.3%
Q3 FY2018Sep 30, 2018$138.84M+7.3%
Q2 FY2018Jun 30, 2018$136.07M+5.3%
Q1 FY2018Mar 31, 2018$134.64M+11.5%
Q4 FY2017Dec 31, 2017$136.86M+10.0%
Q3 FY2017Sep 30, 2017$129.40M–
Q2 FY2017Jun 30, 2017$129.21M–
Q1 FY2017Mar 31, 2017$120.72M–
Q4 FY2016Dec 31, 2016$124.39M–

More Chemed figures

See a number that looks wrong?